Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Peripheral Arterial Disease | 11 | 2024 | 1308 | 2.170 |
Why?
|
Lower Extremity | 14 | 2023 | 1219 | 1.610 |
Why?
|
American Heart Association | 11 | 2024 | 1045 | 1.490 |
Why?
|
Advisory Committees | 6 | 2017 | 796 | 1.030 |
Why?
|
Progeria | 7 | 2023 | 182 | 0.990 |
Why?
|
Vasodilation | 20 | 2009 | 969 | 0.970 |
Why?
|
Cardiology | 10 | 2024 | 1696 | 0.930 |
Why?
|
Peripheral Vascular Diseases | 10 | 2017 | 489 | 0.910 |
Why?
|
Brachial Artery | 16 | 2009 | 374 | 0.840 |
Why?
|
Ultrasonography, Doppler | 8 | 2020 | 462 | 0.730 |
Why?
|
Ankle Brachial Index | 3 | 2018 | 164 | 0.700 |
Why?
|
Arteries | 5 | 2020 | 1120 | 0.690 |
Why?
|
Disease Management | 5 | 2021 | 2530 | 0.680 |
Why?
|
Pulmonary Embolism | 7 | 2023 | 2596 | 0.640 |
Why?
|
Societies, Medical | 11 | 2018 | 3953 | 0.620 |
Why?
|
Nitroglycerin | 8 | 2016 | 331 | 0.590 |
Why?
|
Practice Guidelines as Topic | 9 | 2016 | 7423 | 0.590 |
Why?
|
Thromboembolism | 4 | 2016 | 1001 | 0.550 |
Why?
|
Perioperative Care | 6 | 2024 | 1042 | 0.540 |
Why?
|
Endothelium, Vascular | 16 | 2009 | 4423 | 0.520 |
Why?
|
Vascular Diseases | 5 | 2020 | 1161 | 0.460 |
Why?
|
Takayasu Arteritis | 1 | 2015 | 106 | 0.440 |
Why?
|
Carotid Arteries | 9 | 2017 | 932 | 0.440 |
Why?
|
Arteriosclerosis | 7 | 2004 | 1055 | 0.430 |
Why?
|
Hypertrophy, Right Ventricular | 1 | 2014 | 109 | 0.430 |
Why?
|
Angina Pectoris | 1 | 2016 | 957 | 0.410 |
Why?
|
Arterial Occlusive Diseases | 5 | 2008 | 742 | 0.380 |
Why?
|
Carotid Stenosis | 6 | 2016 | 857 | 0.370 |
Why?
|
Exercise Tolerance | 1 | 2016 | 841 | 0.370 |
Why?
|
Pulmonary Artery | 3 | 2016 | 1937 | 0.370 |
Why?
|
Peroneal Neuropathies | 1 | 2010 | 22 | 0.350 |
Why?
|
Stroke Volume | 1 | 2024 | 5595 | 0.350 |
Why?
|
Giant Cell Arteritis | 3 | 2020 | 308 | 0.340 |
Why?
|
Intermittent Claudication | 4 | 2017 | 305 | 0.330 |
Why?
|
Regional Blood Flow | 8 | 2009 | 1479 | 0.330 |
Why?
|
Ankle | 2 | 2019 | 353 | 0.330 |
Why?
|
Angiography | 7 | 2020 | 1589 | 0.320 |
Why?
|
Estrogen Replacement Therapy | 5 | 2000 | 1206 | 0.310 |
Why?
|
Diagnostic Imaging | 8 | 2018 | 3530 | 0.310 |
Why?
|
Venous Thromboembolism | 5 | 2024 | 1883 | 0.300 |
Why?
|
Leg | 6 | 2020 | 1088 | 0.290 |
Why?
|
Carotid Artery Diseases | 3 | 2011 | 872 | 0.290 |
Why?
|
Femoral Artery | 4 | 2011 | 825 | 0.280 |
Why?
|
Cardiovascular Diseases | 13 | 2024 | 15645 | 0.280 |
Why?
|
Mental Processes | 1 | 2008 | 242 | 0.270 |
Why?
|
Radial Artery | 1 | 2008 | 187 | 0.270 |
Why?
|
Blood Vessels | 2 | 2006 | 1113 | 0.260 |
Why?
|
Veins | 4 | 2020 | 768 | 0.260 |
Why?
|
Temporal Arteries | 2 | 2017 | 155 | 0.260 |
Why?
|
Ultrasonography, Interventional | 6 | 2017 | 1519 | 0.250 |
Why?
|
Stomach Neoplasms | 1 | 2016 | 1469 | 0.250 |
Why?
|
Pulsatile Flow | 4 | 2012 | 318 | 0.250 |
Why?
|
Aortic Diseases | 3 | 2014 | 741 | 0.250 |
Why?
|
Oscillometry | 1 | 2005 | 151 | 0.240 |
Why?
|
Humans | 122 | 2024 | 765926 | 0.240 |
Why?
|
Embolism, Cholesterol | 1 | 2004 | 32 | 0.230 |
Why?
|
Insurance Benefits | 2 | 2016 | 186 | 0.220 |
Why?
|
Magnetic Resonance Angiography | 8 | 2020 | 1429 | 0.220 |
Why?
|
Saphenous Vein | 4 | 2009 | 519 | 0.210 |
Why?
|
Aneurysm, False | 2 | 2006 | 264 | 0.210 |
Why?
|
Blood Pressure | 10 | 2018 | 8530 | 0.210 |
Why?
|
Foot Diseases | 1 | 2004 | 148 | 0.210 |
Why?
|
Ischemia | 4 | 2023 | 1901 | 0.200 |
Why?
|
Exercise | 2 | 2019 | 5936 | 0.200 |
Why?
|
Iliac Artery | 2 | 2020 | 344 | 0.190 |
Why?
|
Heart Failure | 2 | 2024 | 11837 | 0.190 |
Why?
|
Thoracic Outlet Syndrome | 2 | 2015 | 97 | 0.190 |
Why?
|
Stents | 5 | 2016 | 3191 | 0.190 |
Why?
|
Endarterectomy, Carotid | 3 | 2016 | 556 | 0.190 |
Why?
|
Blood Pressure Determination | 1 | 2005 | 646 | 0.190 |
Why?
|
Heart Ventricles | 1 | 2014 | 3833 | 0.190 |
Why?
|
Vasomotor System | 2 | 1999 | 208 | 0.180 |
Why?
|
United States | 29 | 2024 | 72909 | 0.180 |
Why?
|
Aortic Aneurysm, Abdominal | 4 | 2018 | 1248 | 0.180 |
Why?
|
Aortography | 2 | 2020 | 423 | 0.180 |
Why?
|
Estradiol | 4 | 2008 | 1947 | 0.180 |
Why?
|
Geriatric Assessment | 1 | 2008 | 1422 | 0.180 |
Why?
|
Coronary Vessels | 5 | 2016 | 3094 | 0.180 |
Why?
|
Vascular Patency | 5 | 2010 | 914 | 0.170 |
Why?
|
Aged | 43 | 2023 | 171163 | 0.170 |
Why?
|
Retinal Artery | 1 | 2021 | 108 | 0.170 |
Why?
|
Retinal Artery Occlusion | 1 | 2021 | 81 | 0.170 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2024 | 426 | 0.170 |
Why?
|
Ultrasonography | 12 | 2014 | 5987 | 0.170 |
Why?
|
Gangrene | 3 | 2023 | 92 | 0.170 |
Why?
|
Aortitis | 1 | 2020 | 77 | 0.170 |
Why?
|
Radiology | 5 | 2017 | 2105 | 0.170 |
Why?
|
Female | 71 | 2023 | 396141 | 0.160 |
Why?
|
Venous Insufficiency | 2 | 2011 | 109 | 0.160 |
Why?
|
Male | 62 | 2023 | 363815 | 0.160 |
Why?
|
Tomography, X-Ray Computed | 6 | 2015 | 20690 | 0.160 |
Why?
|
Popliteal Artery | 3 | 2009 | 311 | 0.160 |
Why?
|
Predictive Value of Tests | 13 | 2020 | 15401 | 0.160 |
Why?
|
Thrombin | 1 | 2001 | 601 | 0.160 |
Why?
|
Hemostatics | 1 | 2001 | 247 | 0.160 |
Why?
|
Venous Thrombosis | 3 | 2020 | 1319 | 0.160 |
Why?
|
Adenocarcinoma | 1 | 2016 | 6360 | 0.150 |
Why?
|
Ventricular Function, Left | 2 | 2024 | 3930 | 0.150 |
Why?
|
Prognosis | 9 | 2024 | 29890 | 0.140 |
Why?
|
Medicare | 8 | 2023 | 6815 | 0.140 |
Why?
|
Progesterone | 2 | 1999 | 751 | 0.140 |
Why?
|
Aging | 3 | 2011 | 8725 | 0.140 |
Why?
|
Middle Aged | 41 | 2020 | 223016 | 0.140 |
Why?
|
Angiography, Digital Subtraction | 2 | 2017 | 331 | 0.140 |
Why?
|
Ultrasonography, Doppler, Duplex | 7 | 2012 | 198 | 0.140 |
Why?
|
Coronary Artery Disease | 5 | 2016 | 6544 | 0.140 |
Why?
|
Inflammation Mediators | 1 | 2005 | 1886 | 0.130 |
Why?
|
Risk Factors | 22 | 2024 | 74850 | 0.130 |
Why?
|
Evidence-Based Medicine | 7 | 2018 | 3690 | 0.130 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2009 | 2157 | 0.130 |
Why?
|
Treatment Outcome | 22 | 2023 | 65194 | 0.130 |
Why?
|
Quality of Life | 2 | 2019 | 13463 | 0.130 |
Why?
|
Piperidines | 2 | 2016 | 1664 | 0.130 |
Why?
|
Aortic Aneurysm | 1 | 2020 | 649 | 0.130 |
Why?
|
Exercise Test | 2 | 2018 | 2185 | 0.130 |
Why?
|
Monitoring, Immunologic | 1 | 2015 | 99 | 0.120 |
Why?
|
Hypothermia | 1 | 2017 | 190 | 0.120 |
Why?
|
Education, Medical, Continuing | 1 | 2020 | 829 | 0.120 |
Why?
|
Verapamil | 1 | 2015 | 242 | 0.120 |
Why?
|
Vitamin E | 1 | 1999 | 872 | 0.120 |
Why?
|
Mentors | 1 | 2020 | 671 | 0.120 |
Why?
|
Coronary Stenosis | 2 | 2017 | 798 | 0.120 |
Why?
|
Consensus | 4 | 2020 | 3202 | 0.120 |
Why?
|
Constriction, Pathologic | 1 | 2018 | 1102 | 0.120 |
Why?
|
Fontan Procedure | 2 | 2011 | 805 | 0.120 |
Why?
|
Pulse | 3 | 2017 | 217 | 0.110 |
Why?
|
Pravastatin | 1 | 2016 | 391 | 0.110 |
Why?
|
Pain | 3 | 2017 | 5077 | 0.110 |
Why?
|
Cognition Disorders | 1 | 2008 | 3965 | 0.110 |
Why?
|
Coronary Thrombosis | 1 | 2016 | 440 | 0.110 |
Why?
|
Transplantation Immunology | 1 | 2015 | 540 | 0.110 |
Why?
|
Estrogens | 3 | 2000 | 1528 | 0.110 |
Why?
|
Rest | 1 | 2018 | 940 | 0.110 |
Why?
|
Whole Body Imaging | 1 | 2015 | 281 | 0.110 |
Why?
|
Facial Transplantation | 1 | 2015 | 220 | 0.100 |
Why?
|
Anesthesia, Obstetrical | 1 | 2015 | 234 | 0.100 |
Why?
|
Arm | 2 | 2008 | 588 | 0.100 |
Why?
|
Oxygen | 1 | 2024 | 4246 | 0.100 |
Why?
|
Vascular Resistance | 1 | 1996 | 939 | 0.100 |
Why?
|
Arteriovenous Fistula | 1 | 2016 | 318 | 0.100 |
Why?
|
Farnesyltranstransferase | 1 | 2012 | 70 | 0.100 |
Why?
|
Patient Care Planning | 1 | 2018 | 903 | 0.100 |
Why?
|
Upper Extremity Deep Vein Thrombosis | 1 | 2012 | 25 | 0.100 |
Why?
|
Pyridines | 2 | 2016 | 2885 | 0.100 |
Why?
|
Acute Disease | 5 | 2017 | 7236 | 0.100 |
Why?
|
Health Services Misuse | 1 | 2014 | 245 | 0.100 |
Why?
|
Heart Defects, Congenital | 3 | 2023 | 4712 | 0.100 |
Why?
|
Insulin Resistance | 4 | 2007 | 3988 | 0.100 |
Why?
|
Adult | 31 | 2020 | 223088 | 0.100 |
Why?
|
Exercise Therapy | 1 | 2019 | 936 | 0.100 |
Why?
|
Ventricular Function, Right | 1 | 2016 | 629 | 0.100 |
Why?
|
Diphosphonates | 1 | 2016 | 625 | 0.090 |
Why?
|
Syncope | 1 | 2014 | 431 | 0.090 |
Why?
|
Atherosclerosis | 4 | 2010 | 3419 | 0.090 |
Why?
|
Glucocorticoids | 2 | 2017 | 2155 | 0.090 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2015 | 772 | 0.090 |
Why?
|
Patient Care Management | 1 | 2014 | 301 | 0.090 |
Why?
|
Myocardium | 2 | 2018 | 4764 | 0.090 |
Why?
|
Nitric Oxide | 6 | 2009 | 2141 | 0.090 |
Why?
|
Aorta, Abdominal | 2 | 2012 | 626 | 0.090 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 2015 | 518 | 0.090 |
Why?
|
Myocardial Contraction | 1 | 2016 | 1516 | 0.090 |
Why?
|
Stockings, Compression | 1 | 2010 | 36 | 0.090 |
Why?
|
Anticoagulants | 4 | 2009 | 4856 | 0.090 |
Why?
|
Imidazoles | 1 | 2016 | 1164 | 0.090 |
Why?
|
Pulmonary Veins | 1 | 2016 | 757 | 0.090 |
Why?
|
Myocardial Infarction | 4 | 2016 | 11508 | 0.090 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2016 | 645 | 0.090 |
Why?
|
Blood Flow Velocity | 2 | 2011 | 1377 | 0.090 |
Why?
|
Hypesthesia | 1 | 2010 | 106 | 0.080 |
Why?
|
Postoperative Care | 1 | 2016 | 1475 | 0.080 |
Why?
|
Forearm | 3 | 1997 | 426 | 0.080 |
Why?
|
Vascular Surgical Procedures | 2 | 2010 | 1506 | 0.080 |
Why?
|
Retrospective Studies | 13 | 2023 | 81537 | 0.080 |
Why?
|
Thoracic Injuries | 1 | 2012 | 288 | 0.080 |
Why?
|
Postmenopause | 3 | 2008 | 2517 | 0.080 |
Why?
|
Stroke | 3 | 2016 | 9739 | 0.080 |
Why?
|
Surgical Procedures, Operative | 4 | 2024 | 1930 | 0.080 |
Why?
|
Muscle, Smooth, Vascular | 3 | 2004 | 1494 | 0.080 |
Why?
|
Heart | 2 | 2018 | 4419 | 0.080 |
Why?
|
Risk Assessment | 4 | 2024 | 24275 | 0.080 |
Why?
|
Enoxaparin | 2 | 2009 | 390 | 0.080 |
Why?
|
Enzyme Inhibitors | 5 | 2012 | 3716 | 0.080 |
Why?
|
Insurance, Health, Reimbursement | 2 | 2015 | 388 | 0.080 |
Why?
|
Prospective Studies | 14 | 2023 | 54807 | 0.080 |
Why?
|
Tropomyosin | 2 | 1985 | 103 | 0.070 |
Why?
|
Sensitivity and Specificity | 2 | 2018 | 14643 | 0.070 |
Why?
|
Echocardiography | 3 | 2018 | 5040 | 0.070 |
Why?
|
Imaging, Three-Dimensional | 2 | 2012 | 4037 | 0.070 |
Why?
|
Hydrochlorothiazide | 1 | 2007 | 95 | 0.070 |
Why?
|
Hyperemia | 5 | 2009 | 223 | 0.070 |
Why?
|
Blood Vessel Prosthesis Implantation | 2 | 2015 | 1456 | 0.070 |
Why?
|
Cardiovascular System | 1 | 2014 | 838 | 0.070 |
Why?
|
Wrist | 1 | 2008 | 230 | 0.070 |
Why?
|
Graft Occlusion, Vascular | 1 | 2010 | 539 | 0.070 |
Why?
|
Tachycardia, Ventricular | 1 | 2015 | 1313 | 0.070 |
Why?
|
Plethysmography | 1 | 2006 | 172 | 0.070 |
Why?
|
Manometry | 1 | 2009 | 457 | 0.070 |
Why?
|
Thrombosis | 1 | 2020 | 2955 | 0.070 |
Why?
|
Pain Measurement | 1 | 2016 | 3558 | 0.060 |
Why?
|
Radiography, Interventional | 1 | 2013 | 1128 | 0.060 |
Why?
|
Posture | 1 | 2010 | 955 | 0.060 |
Why?
|
Combined Modality Therapy | 2 | 2016 | 8522 | 0.060 |
Why?
|
Tetralogy of Fallot | 1 | 2011 | 629 | 0.060 |
Why?
|
Aorta, Thoracic | 1 | 2012 | 1109 | 0.060 |
Why?
|
Wounds, Nonpenetrating | 1 | 2012 | 806 | 0.060 |
Why?
|
Ultrasonography, Doppler, Color | 1 | 2006 | 234 | 0.060 |
Why?
|
Chi-Square Distribution | 2 | 2016 | 3430 | 0.060 |
Why?
|
Principal Component Analysis | 1 | 2008 | 947 | 0.060 |
Why?
|
Likelihood Functions | 1 | 2008 | 993 | 0.060 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2008 | 428 | 0.060 |
Why?
|
Renal Artery | 1 | 2006 | 355 | 0.060 |
Why?
|
Blood Volume | 1 | 2006 | 544 | 0.060 |
Why?
|
Peptides | 1 | 2016 | 4331 | 0.060 |
Why?
|
Drug Therapy, Combination | 4 | 2016 | 6306 | 0.060 |
Why?
|
Renin-Angiotensin System | 2 | 2007 | 736 | 0.060 |
Why?
|
Recurrence | 1 | 2016 | 8492 | 0.060 |
Why?
|
Diuretics | 1 | 2007 | 611 | 0.060 |
Why?
|
Polysaccharides | 2 | 2007 | 1017 | 0.060 |
Why?
|
Hypertension | 2 | 2018 | 8616 | 0.060 |
Why?
|
Chronic Disease | 2 | 2016 | 9351 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2021 | 10380 | 0.050 |
Why?
|
C-Reactive Protein | 3 | 2020 | 3851 | 0.050 |
Why?
|
Spironolactone | 1 | 2007 | 415 | 0.050 |
Why?
|
Contrast Media | 3 | 2012 | 5330 | 0.050 |
Why?
|
Bioreactors | 1 | 2024 | 244 | 0.050 |
Why?
|
Pericardial Effusion | 1 | 2005 | 245 | 0.050 |
Why?
|
Accreditation | 1 | 2006 | 476 | 0.050 |
Why?
|
Automation | 1 | 2005 | 585 | 0.050 |
Why?
|
Sex Characteristics | 3 | 2023 | 2645 | 0.050 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2013 | 1563 | 0.050 |
Why?
|
Adolescent | 10 | 2018 | 88811 | 0.050 |
Why?
|
Fingers | 1 | 2006 | 509 | 0.050 |
Why?
|
Thiazolidinediones | 1 | 2006 | 459 | 0.050 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2005 | 694 | 0.050 |
Why?
|
Reproducibility of Results | 3 | 2018 | 20133 | 0.050 |
Why?
|
Hand | 1 | 2008 | 908 | 0.050 |
Why?
|
Telemedicine | 1 | 2020 | 3108 | 0.050 |
Why?
|
General Surgery | 1 | 2014 | 1722 | 0.050 |
Why?
|
Cacao | 1 | 2003 | 98 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3109 | 0.050 |
Why?
|
Biphenyl Compounds | 1 | 2008 | 1019 | 0.050 |
Why?
|
Coronary Circulation | 2 | 2007 | 1601 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3231 | 0.050 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2007 | 391 | 0.050 |
Why?
|
Graft Rejection | 1 | 2015 | 4503 | 0.050 |
Why?
|
Endovascular Procedures | 1 | 2016 | 2219 | 0.050 |
Why?
|
Aged, 80 and over | 9 | 2016 | 59496 | 0.050 |
Why?
|
Acetylcholine | 3 | 1999 | 628 | 0.050 |
Why?
|
Insulin | 5 | 2008 | 6603 | 0.050 |
Why?
|
Follow-Up Studies | 8 | 2016 | 39228 | 0.050 |
Why?
|
Tetrazoles | 1 | 2008 | 918 | 0.050 |
Why?
|
Severity of Illness Index | 2 | 2016 | 15878 | 0.050 |
Why?
|
District of Columbia | 1 | 2001 | 159 | 0.050 |
Why?
|
Outpatients | 2 | 2009 | 1595 | 0.050 |
Why?
|
Positron-Emission Tomography | 2 | 2015 | 6542 | 0.050 |
Why?
|
Aortic Valve Stenosis | 1 | 2013 | 2022 | 0.050 |
Why?
|
Washington | 1 | 2001 | 315 | 0.050 |
Why?
|
Coronary Disease | 3 | 2004 | 5919 | 0.050 |
Why?
|
CD40 Ligand | 1 | 2003 | 528 | 0.050 |
Why?
|
Survival Analysis | 3 | 2015 | 10086 | 0.040 |
Why?
|
Progestins | 2 | 2000 | 300 | 0.040 |
Why?
|
Vena Cava, Inferior | 1 | 2024 | 463 | 0.040 |
Why?
|
Flavonoids | 1 | 2003 | 445 | 0.040 |
Why?
|
Pennsylvania | 1 | 2001 | 615 | 0.040 |
Why?
|
Diabetic Nephropathies | 1 | 2007 | 968 | 0.040 |
Why?
|
Child, Preschool | 5 | 2018 | 42510 | 0.040 |
Why?
|
Limb Salvage | 1 | 2023 | 488 | 0.040 |
Why?
|
Electrocardiography | 3 | 2018 | 6409 | 0.040 |
Why?
|
Diagnosis, Differential | 4 | 2020 | 12973 | 0.040 |
Why?
|
Secondary Prevention | 2 | 2021 | 1470 | 0.040 |
Why?
|
Observer Variation | 3 | 2015 | 2611 | 0.040 |
Why?
|
Dilatation, Pathologic | 1 | 2020 | 527 | 0.040 |
Why?
|
Hemodynamics | 2 | 2008 | 4186 | 0.040 |
Why?
|
Foot | 1 | 2023 | 575 | 0.040 |
Why?
|
Vasodilator Agents | 4 | 2009 | 988 | 0.040 |
Why?
|
Coronary Artery Bypass | 2 | 2017 | 2188 | 0.040 |
Why?
|
Injections | 1 | 2001 | 839 | 0.040 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2014 | 8924 | 0.040 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2012 | 3360 | 0.040 |
Why?
|
Beverages | 1 | 2003 | 819 | 0.040 |
Why?
|
Craniotomy | 1 | 2002 | 737 | 0.040 |
Why?
|
Antihypertensive Agents | 1 | 2008 | 2028 | 0.040 |
Why?
|
Heart Murmurs | 1 | 2018 | 92 | 0.040 |
Why?
|
Platelet Count | 1 | 2020 | 784 | 0.040 |
Why?
|
Echocardiography, Transesophageal | 1 | 2004 | 1093 | 0.040 |
Why?
|
Warfarin | 1 | 2006 | 1494 | 0.040 |
Why?
|
Neoplasms | 2 | 2023 | 22340 | 0.040 |
Why?
|
Fertilization | 1 | 2018 | 197 | 0.040 |
Why?
|
Cross-Over Studies | 2 | 2007 | 2108 | 0.040 |
Why?
|
Blood Platelets | 2 | 1985 | 2464 | 0.040 |
Why?
|
Stress, Mechanical | 2 | 2016 | 1670 | 0.040 |
Why?
|
Homocystine | 1 | 1997 | 21 | 0.040 |
Why?
|
Physicians | 1 | 2015 | 4591 | 0.040 |
Why?
|
Monitoring, Physiologic | 2 | 2015 | 1793 | 0.030 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2004 | 1657 | 0.030 |
Why?
|
Time Factors | 6 | 2016 | 40097 | 0.030 |
Why?
|
Adipose Tissue | 2 | 2006 | 3314 | 0.030 |
Why?
|
Subclavian Artery | 1 | 2017 | 138 | 0.030 |
Why?
|
Wound Healing | 1 | 2008 | 2794 | 0.030 |
Why?
|
Drug Administration Schedule | 3 | 2012 | 4851 | 0.030 |
Why?
|
Sex Factors | 3 | 2020 | 10611 | 0.030 |
Why?
|
Protein Prenylation | 1 | 2016 | 69 | 0.030 |
Why?
|
Methylprednisolone | 1 | 2017 | 386 | 0.030 |
Why?
|
Cohort Studies | 7 | 2015 | 41680 | 0.030 |
Why?
|
Aneurysm | 1 | 1999 | 343 | 0.030 |
Why?
|
Triglycerides | 2 | 2004 | 2440 | 0.030 |
Why?
|
Biopsy | 2 | 2017 | 6766 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2012 | 10727 | 0.030 |
Why?
|
Thrombectomy | 1 | 2020 | 676 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2005 | 3225 | 0.030 |
Why?
|
Anastomosis, Surgical | 3 | 2008 | 992 | 0.030 |
Why?
|
Neuropsychological Tests | 1 | 2008 | 7116 | 0.030 |
Why?
|
Tissue Plasminogen Activator | 1 | 2021 | 1164 | 0.030 |
Why?
|
Carrier Proteins | 2 | 1985 | 4909 | 0.030 |
Why?
|
Inflammation | 2 | 2020 | 10843 | 0.030 |
Why?
|
Cholesterol | 3 | 1999 | 2902 | 0.030 |
Why?
|
Syndrome | 1 | 2021 | 3271 | 0.030 |
Why?
|
Emergencies | 1 | 2021 | 1221 | 0.030 |
Why?
|
omega-N-Methylarginine | 2 | 2009 | 108 | 0.030 |
Why?
|
NG-Nitroarginine Methyl Ester | 2 | 2006 | 261 | 0.030 |
Why?
|
Reference Values | 4 | 2007 | 4909 | 0.030 |
Why?
|
Lipid Metabolism | 1 | 2003 | 1893 | 0.030 |
Why?
|
Peripartum Period | 1 | 2015 | 138 | 0.030 |
Why?
|
Education, Medical, Graduate | 1 | 2006 | 2419 | 0.030 |
Why?
|
Age Factors | 4 | 2015 | 18382 | 0.030 |
Why?
|
Program Development | 1 | 2020 | 1297 | 0.030 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2005 | 4342 | 0.030 |
Why?
|
Boston | 2 | 2010 | 9334 | 0.030 |
Why?
|
Triage | 1 | 2021 | 994 | 0.030 |
Why?
|
Pharmaceutical Preparations | 1 | 2022 | 1084 | 0.030 |
Why?
|
Child | 5 | 2018 | 80568 | 0.030 |
Why?
|
Reproductive Techniques, Assisted | 1 | 2018 | 503 | 0.030 |
Why?
|
Homocysteine | 1 | 1997 | 638 | 0.030 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2016 | 577 | 0.030 |
Why?
|
Aorta | 1 | 2021 | 2040 | 0.030 |
Why?
|
DNA, Viral | 1 | 2020 | 2196 | 0.030 |
Why?
|
Professional Practice | 1 | 2015 | 314 | 0.030 |
Why?
|
Tunica Intima | 1 | 2015 | 455 | 0.030 |
Why?
|
Hypoglycemic Agents | 1 | 2006 | 3106 | 0.030 |
Why?
|
Anesthesia, Epidural | 1 | 2015 | 231 | 0.030 |
Why?
|
Elasticity | 2 | 2006 | 652 | 0.030 |
Why?
|
Registries | 2 | 2022 | 8346 | 0.030 |
Why?
|
Curriculum | 1 | 2006 | 3784 | 0.030 |
Why?
|
Prednisone | 1 | 2017 | 1566 | 0.030 |
Why?
|
Potassium | 2 | 2007 | 1312 | 0.030 |
Why?
|
Ascorbic Acid | 1 | 1996 | 657 | 0.030 |
Why?
|
Anesthetics, Intravenous | 1 | 2015 | 394 | 0.020 |
Why?
|
Blood Glucose | 4 | 2008 | 6422 | 0.020 |
Why?
|
Emergency Service, Hospital | 1 | 2012 | 7871 | 0.020 |
Why?
|
Cerebral Revascularization | 1 | 2015 | 260 | 0.020 |
Why?
|
Palpation | 1 | 2012 | 166 | 0.020 |
Why?
|
Receptors, Estrogen | 1 | 2000 | 2242 | 0.020 |
Why?
|
Infusions, Intravenous | 2 | 2009 | 2227 | 0.020 |
Why?
|
Transplantation, Autologous | 3 | 2004 | 2125 | 0.020 |
Why?
|
Fentanyl | 1 | 2015 | 451 | 0.020 |
Why?
|
Program Evaluation | 1 | 2020 | 2502 | 0.020 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2020 | 2027 | 0.020 |
Why?
|
Meglumine | 1 | 2012 | 143 | 0.020 |
Why?
|
Serum Albumin | 2 | 1985 | 673 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 1 | 2020 | 1881 | 0.020 |
Why?
|
Multivariate Analysis | 3 | 2016 | 12059 | 0.020 |
Why?
|
Drug-Eluting Stents | 1 | 2017 | 680 | 0.020 |
Why?
|
Kidney | 1 | 2007 | 7073 | 0.020 |
Why?
|
Survival Rate | 1 | 2005 | 12822 | 0.020 |
Why?
|
Renin | 2 | 2007 | 647 | 0.020 |
Why?
|
Gonadal Steroid Hormones | 1 | 1995 | 706 | 0.020 |
Why?
|
Prosthesis Failure | 1 | 2016 | 1194 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2020 | 1802 | 0.020 |
Why?
|
Comparative Effectiveness Research | 1 | 2016 | 713 | 0.020 |
Why?
|
Radiopharmaceuticals | 1 | 2020 | 2701 | 0.020 |
Why?
|
Lipoproteins, HDL | 1 | 1995 | 676 | 0.020 |
Why?
|
Ischemic Attack, Transient | 1 | 2016 | 871 | 0.020 |
Why?
|
Double-Blind Method | 3 | 2002 | 12417 | 0.020 |
Why?
|
Lipoprotein(a) | 1 | 1995 | 488 | 0.020 |
Why?
|
Neurosurgical Procedures | 1 | 2021 | 2077 | 0.020 |
Why?
|
Phenotype | 1 | 2008 | 16714 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 3 | 2008 | 36547 | 0.020 |
Why?
|
Life Tables | 2 | 2000 | 366 | 0.020 |
Why?
|
Odds Ratio | 2 | 2016 | 9656 | 0.020 |
Why?
|
Lamin Type A | 1 | 2010 | 186 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2016 | 2111 | 0.020 |
Why?
|
Emergency Medical Services | 1 | 2021 | 1937 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2020 | 2726 | 0.020 |
Why?
|
Vomiting | 1 | 2012 | 646 | 0.020 |
Why?
|
Aldosterone | 2 | 2008 | 881 | 0.020 |
Why?
|
Preoperative Care | 1 | 2018 | 2248 | 0.020 |
Why?
|
Cholesterol, LDL | 1 | 1998 | 2395 | 0.020 |
Why?
|
Liver | 1 | 2024 | 7559 | 0.020 |
Why?
|
Gadolinium DTPA | 1 | 2012 | 822 | 0.020 |
Why?
|
India | 2 | 2006 | 2334 | 0.020 |
Why?
|
Organometallic Compounds | 1 | 2012 | 645 | 0.020 |
Why?
|
Disease Progression | 2 | 2020 | 13614 | 0.020 |
Why?
|
Rats | 1 | 2024 | 23708 | 0.020 |
Why?
|
Propensity Score | 1 | 2016 | 1971 | 0.020 |
Why?
|
Delphi Technique | 1 | 2012 | 893 | 0.020 |
Why?
|
Antioxidants | 1 | 1996 | 1671 | 0.020 |
Why?
|
Adaptation, Physiological | 2 | 2008 | 1308 | 0.020 |
Why?
|
Cross-Sectional Studies | 3 | 2018 | 26282 | 0.020 |
Why?
|
Upper Extremity | 1 | 2012 | 681 | 0.020 |
Why?
|
Chromatography, Affinity | 2 | 1985 | 520 | 0.020 |
Why?
|
Abdominal Pain | 1 | 2013 | 1069 | 0.020 |
Why?
|
Catecholamines | 1 | 2008 | 385 | 0.020 |
Why?
|
Length of Stay | 1 | 2020 | 6486 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2023 | 14745 | 0.020 |
Why?
|
Case-Control Studies | 4 | 2009 | 22228 | 0.020 |
Why?
|
Renal Circulation | 1 | 2007 | 288 | 0.020 |
Why?
|
Menopause | 1 | 1994 | 1659 | 0.020 |
Why?
|
Factor X | 1 | 2006 | 64 | 0.020 |
Why?
|
Administration, Sublingual | 1 | 2006 | 60 | 0.020 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2009 | 707 | 0.020 |
Why?
|
Injections, Subcutaneous | 1 | 2007 | 682 | 0.020 |
Why?
|
Hemorrhage | 2 | 2009 | 3466 | 0.020 |
Why?
|
Blood Chemical Analysis | 1 | 2008 | 434 | 0.020 |
Why?
|
Growth | 1 | 2008 | 365 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2007 | 12235 | 0.020 |
Why?
|
Young Adult | 2 | 2011 | 59857 | 0.020 |
Why?
|
Coronary Angiography | 1 | 2017 | 4498 | 0.020 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 2 | 1985 | 1724 | 0.020 |
Why?
|
Administration, Oral | 2 | 2009 | 4016 | 0.020 |
Why?
|
Bone and Bones | 1 | 2016 | 2555 | 0.020 |
Why?
|
Glucose Clamp Technique | 1 | 2006 | 262 | 0.020 |
Why?
|
Diarrhea | 1 | 2012 | 1315 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2016 | 6503 | 0.020 |
Why?
|
Phenylephrine | 1 | 2006 | 291 | 0.020 |
Why?
|
Lipids | 2 | 2007 | 3317 | 0.020 |
Why?
|
Cause of Death | 1 | 2016 | 3715 | 0.020 |
Why?
|
Isoelectric Focusing | 1 | 1985 | 148 | 0.020 |
Why?
|
Fatigue | 1 | 2012 | 1553 | 0.020 |
Why?
|
Pericardiocentesis | 1 | 2005 | 78 | 0.020 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2016 | 2769 | 0.010 |
Why?
|
Chromatography, Gel | 1 | 1985 | 631 | 0.010 |
Why?
|
Actinin | 1 | 1985 | 165 | 0.010 |
Why?
|
Pilot Projects | 2 | 2007 | 8724 | 0.010 |
Why?
|
Sodium Chloride | 1 | 2006 | 578 | 0.010 |
Why?
|
Animals | 5 | 2024 | 168735 | 0.010 |
Why?
|
Subcutaneous Tissue | 1 | 2004 | 131 | 0.010 |
Why?
|
Renal Dialysis | 1 | 2013 | 1791 | 0.010 |
Why?
|
Patient Selection | 1 | 2015 | 4248 | 0.010 |
Why?
|
Gravity Suits | 1 | 2002 | 13 | 0.010 |
Why?
|
Albuminuria | 1 | 2007 | 659 | 0.010 |
Why?
|
Nitric Oxide Synthase | 1 | 2006 | 911 | 0.010 |
Why?
|
Guideline Adherence | 1 | 2013 | 2234 | 0.010 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2004 | 393 | 0.010 |
Why?
|
Molecular Weight | 1 | 1985 | 2160 | 0.010 |
Why?
|
Sodium | 1 | 2008 | 1591 | 0.010 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 2004 | 239 | 0.010 |
Why?
|
Vasoconstrictor Agents | 1 | 2006 | 653 | 0.010 |
Why?
|
Weight Gain | 1 | 2012 | 2356 | 0.010 |
Why?
|
Creatinine | 1 | 2008 | 1916 | 0.010 |
Why?
|
Quality Assurance, Health Care | 1 | 2012 | 2170 | 0.010 |
Why?
|
Rabbits | 2 | 1985 | 4729 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12529 | 0.010 |
Why?
|
Systole | 1 | 2003 | 935 | 0.010 |
Why?
|
Logistic Models | 1 | 2016 | 13273 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 2002 | 9065 | 0.010 |
Why?
|
Brain | 1 | 2008 | 27179 | 0.010 |
Why?
|
Artifacts | 1 | 2010 | 1896 | 0.010 |
Why?
|
Diastole | 1 | 2003 | 785 | 0.010 |
Why?
|
Solubility | 1 | 2003 | 1077 | 0.010 |
Why?
|
Thrombocytopenia | 1 | 2009 | 1172 | 0.010 |
Why?
|
Bandages | 1 | 2002 | 270 | 0.010 |
Why?
|
Infant | 2 | 2016 | 36426 | 0.010 |
Why?
|
Inguinal Canal | 1 | 2000 | 71 | 0.010 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2007 | 1513 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8721 | 0.010 |
Why?
|
Comorbidity | 1 | 2015 | 10575 | 0.010 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2007 | 1060 | 0.010 |
Why?
|
Postoperative Complications | 2 | 2018 | 15802 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2015 | 8037 | 0.010 |
Why?
|
Radiographic Image Enhancement | 1 | 2004 | 873 | 0.010 |
Why?
|
Analysis of Variance | 2 | 1999 | 6202 | 0.010 |
Why?
|
Administration, Intravaginal | 1 | 1999 | 149 | 0.010 |
Why?
|
Enzyme Precursors | 1 | 1999 | 164 | 0.010 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2003 | 1132 | 0.010 |
Why?
|
Single-Blind Method | 1 | 2003 | 1587 | 0.010 |
Why?
|
Amino Acids | 1 | 1985 | 1709 | 0.010 |
Why?
|
Databases, Factual | 1 | 2014 | 8060 | 0.010 |
Why?
|
Adiponectin | 1 | 2004 | 1120 | 0.010 |
Why?
|
Abdomen | 1 | 2004 | 1135 | 0.010 |
Why?
|
Women's Health | 1 | 2008 | 2081 | 0.010 |
Why?
|
Prevalence | 1 | 1995 | 15828 | 0.010 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 1999 | 254 | 0.010 |
Why?
|
Administration, Cutaneous | 1 | 1999 | 712 | 0.010 |
Why?
|
Nitroprusside | 1 | 1996 | 271 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2007 | 5300 | 0.010 |
Why?
|
Heparin | 1 | 2002 | 1632 | 0.010 |
Why?
|
Cold Temperature | 1 | 1999 | 793 | 0.010 |
Why?
|
Forecasting | 1 | 2004 | 2936 | 0.010 |
Why?
|
Pregnancy | 1 | 2015 | 30230 | 0.010 |
Why?
|
Radiography | 1 | 2004 | 6941 | 0.010 |
Why?
|
Fibrinolytic Agents | 1 | 2002 | 2076 | 0.010 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2007 | 3444 | 0.010 |
Why?
|
Glucose | 1 | 2003 | 4335 | 0.010 |
Why?
|
Linear Models | 1 | 2000 | 5873 | 0.010 |
Why?
|
Proteins | 1 | 2004 | 5994 | 0.010 |
Why?
|
Body Weight | 1 | 1999 | 4627 | 0.000 |
Why?
|
Regression Analysis | 1 | 1997 | 6321 | 0.000 |
Why?
|
Immunosorbent Techniques | 1 | 1985 | 174 | 0.000 |
Why?
|
Trypsin | 1 | 1985 | 487 | 0.000 |
Why?
|
Testosterone | 1 | 1995 | 2495 | 0.000 |
Why?
|
Cross Reactions | 1 | 1985 | 824 | 0.000 |
Why?
|
Body Mass Index | 1 | 1999 | 13042 | 0.000 |
Why?
|
Amino Acid Sequence | 1 | 1985 | 13398 | 0.000 |
Why?
|
Peptide Fragments | 1 | 1985 | 5126 | 0.000 |
Why?
|